Current Duke Appointments & Affiliations
Associate Professor of Medicine
·
2026 - Present
Medicine, Nephrology,
Medicine
Chief, Division of Nephrology
·
2025 - Present
Medicine, Nephrology,
Medicine
Member of Duke Molecular Physiology Institute
·
2019 - Present
Duke Molecular Physiology Institute,
Institutes and Centers
Recent Scholarly Works
Hybrid Community-Electronic Health Record Approaches to Apolipoprotein L1 Kidney Disease Screening and Clinical Trials among Black Individuals.
Journal article J Am Soc Nephrol · August 1, 2026 KEY POINTS: Community engagement achieved high apolipoprotein L1 (APOL1)-mediated kidney disease screening rates but low yield of trial-eligible participants. Electronic health record and health care professional referrals identified more participants with ... Full text Link to item CiteAPOL1-Mediated Kidney Disease and the Emerging Era of Precision Therapy.
Journal article Annu Rev Med · July 21, 2026 APOL1 renal risk genetic variants (G1 and G2) account for a substantial portion of the excess burden of nondiabetic kidney disease among individuals with recent African ancestry (within the past 10,000 years). Apolipoprotein L1 (APOL1)-mediated kidney dise ... Full text Link to item CiteAPOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Journal article Kidney Int · November 2025 In people of African ancestry, apolipoprotein L1 gene (APOL1) variants have been identified as causing increased risk of progressive chronic kidney disease (CKD). In April of 2024, Kidney Disease: Improving Global Outcomes (KDIGO) convened a Controversies ... Full text Link to item CiteRecent Grants
Psychosocial Stress and Role of Kidney Disease
ResearchCo-Mentor · Awarded by National Institutes of Health · 2026 - 2031Maze Therapeutics MZE829-201: An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype
Clinical TrialPrincipal Investigator · Awarded by Maze Therapeutics · 2025 - 2030Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029View All Grants
Education
Yeshiva University, Albert Einstein College of Medicine ·
2009
Ph.D.
Yeshiva University, Albert Einstein College of Medicine ·
2009
M.D.